Finance

Lists
DBV:EPA
DBV Technologies SA
€1.76
-1.29%
(-0.023) 1D
Nov 4, 5:35:03 PM GMT+1  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for DBV...
Open
€1.78
High
€1.84
Low
€1.75
Mkt. cap
610.36M
Avg. vol.
1.32M
Volume
1.17M
52-wk high
€4.50
52-wk low
€1.53
EPS
-€0.64
Shares outstanding
314.39M
No. of employees
170
Open
€1.78
High
€1.84
Low
€1.75
Mkt. cap
610.36M
Avg. vol.
1.32M
Volume
1.17M
52-wk high
€4.50
52-wk low
€1.53
EPS
-€0.64
Shares outstanding
314.39M
No. of employees
170
News stories
From web sources and news partners
Profile
DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration. Wikipedia
About DBV Technologies SA
CEO-
Employees170
FoundedMar 29, 2002
Headquarters-
SectorBiotechnology
Industry-
Websitedbv-technologies.com
Last report
Oct 28, 2026
Fiscal period
Q3 2026
-€0.13 / -€0.15
+14.94%beat
Revenue / Est. (EUR)
1.44M / 583.22K
+146.14%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
645.00K
900.00K
700.00K
1.60M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
32.89M
33.40M
31.20M
47.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
12.80M
15.30M
20.10M
19.30M
Operating expense
45.70M
48.70M
51.30M
66.30M
Total operating expenses
45.70M
48.70M
51.30M
66.30M
Operating income
-45.05M
-47.80M
-50.60M
-64.70M
Other non operating income
-1.00K
-100.00K
-
500.00K
EBT including unusual items
-44.46M
-47.40M
-50.20M
-64.20M
EBT excluding unusual items
-44.46M
-47.40M
-50.20M
-64.20M
Income tax expense
374.00K
200.00K
200.00K
300.00K
Effective tax rate
-0.84%
-0.42%
-0.40%
-0.47%
Other operating expenses
-
-
-
-
Net income
-44.83M
-47.60M
-50.40M
-64.50M
Net profit margin
-6,950.23%
-5,288.89%
-7,200.00%
-4,031.25%
Earnings per share
-
-
-
-
Interest and investment income
597.00K
500.00K
400.00K
-
Interest expense
-
-
-
-
Net interest expenses
597.00K
500.00K
400.00K
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-44.36M
-46.90M
-50.00M
-64.10M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps